A pharmaceutical formulation comprising Ofloxacin or its pharmaceutically acceptable salt is present in the range 50 mg to 250 mg, preferably 100 mg to 200 mg, Ornidazole or its pharmaceutically acceptable salt, present in the range 150 mg to 500 mg, preferably 500mg, and racecadotril or its...